Works matching IS 0937941X AND DT 2023 AND VI 34 AND IP 10
Results: 23
A promising strategy for the diagnosis, treatment, and prevention of osteoporosis (EMS strategy).
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
The importance of structural barriers of osteoporotic hip fracture in the elderly.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Author response to: Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study. Osteoporos Int. 2023 Apr;34(4):763–774.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1815, doi. 10.1007/s00198-023-06873-w
- By:
- Publication type:
- Article
Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naïve patients: two further cases.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Response letter to: "The importance of structural barriers of osteoporotic hip fracture in the elderly".
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Gender differences in osteoporosis.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1805, doi. 10.1007/s00198-023-06858-9
- By:
- Publication type:
- Article
Drug adherence and treatment duration for denosumab and mortality risk among hip fracture patients.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1783, doi. 10.1007/s00198-023-06845-0
- By:
- Publication type:
- Article
Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS).
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1799, doi. 10.1007/s00198-023-06838-z
- By:
- Publication type:
- Article
Drug utilization analysis of osteoporosis medications in seven European electronic health databases.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1771, doi. 10.1007/s00198-023-06837-0
- By:
- Publication type:
- Article
Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1677, doi. 10.1007/s00198-023-06836-1
- By:
- Publication type:
- Article
Author response to OSIN-D-23–00510, "Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?"
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Correction to: Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Establishing a Chinese older hip fracture registry for older patients: a Delphi study to define the focus and key variables for this registry.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1763, doi. 10.1007/s00198-023-06832-5
- By:
- Publication type:
- Article
Comorbidity and risk of infection among patients with hip fracture: a Danish population-based cohort study.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1739, doi. 10.1007/s00198-023-06823-6
- By:
- Publication type:
- Article
Impact of fragility fractures on activities of daily living and productivity in community-dwelling women: a multi-national study.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1751, doi. 10.1007/s00198-023-06822-7
- By:
- Publication type:
- Article
Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Liver enzyme inducing anticonvulsant drug use is associated with prevalent vertebral fracture.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1793, doi. 10.1007/s00198-023-06820-9
- By:
- Publication type:
- Article
Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1729, doi. 10.1007/s00198-023-06818-3
- By:
- Publication type:
- Article
Urinary pentosidine level is associated with the risk of fracture in community-dwelling older adults: a prospective observational study.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1703, doi. 10.1007/s00198-023-06816-5
- By:
- Publication type:
- Article
The effect of intermittent parathyroid hormone on bone lengthening: current evidence to inform future effective interventions.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1657, doi. 10.1007/s00198-023-06809-4
- By:
- Publication type:
- Article
Causal relationship between type 2 diabetes mellitus and bone mineral density: a Mendelian randomization study in an East Asian population.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1719, doi. 10.1007/s00198-023-06807-6
- By:
- Publication type:
- Article
Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1711, doi. 10.1007/s00198-023-06806-7
- By:
- Publication type:
- Article